This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jul;92(7):1167.

doi: 10.1016/j.mayocp.2017.05.001.

In Reply-Bisphosphonates and Osteonecrosis of the Jaw

James S Goodwin¹

Affiliations

PMID: 28688472
DOI: 10.1016/j.mayocp.2017.05.001

Comment

In Reply-Bisphosphonates and Osteonecrosis of the Jaw

James S Goodwin. Mayo Clin Proc. 2017 Jul.

. 2017 Jul;92(7):1167.

doi: 10.1016/j.mayocp.2017.05.001.

Author

James S Goodwin¹

Affiliation

¹ University of Texas Medical Branch, Galveston, TX.

PMID: 28688472
DOI: 10.1016/j.mayocp.2017.05.001

No abstract available

PubMed Disclaimer

Comment on

Risk of Jaw Osteonecrosis After Intravenous Bisphosphonates in Cancer Patients and Patients Without Cancer.
Goodwin JS, Zhou J, Kuo YF, Baillargeon J. Goodwin JS, et al. Mayo Clin Proc. 2017 Jan;92(1):106-113. doi: 10.1016/j.mayocp.2016.09.015. Epub 2016 Nov 19. Mayo Clin Proc. 2017. PMID: 27876314 Free PMC article.
Bisphosphonates and Osteonecrosis of the Jaw.
Khoo TK. Khoo TK. Mayo Clin Proc. 2017 Jul;92(7):1166-1167. doi: 10.1016/j.mayocp.2017.05.002. Mayo Clin Proc. 2017. PMID: 28688470 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information